Cargando…
Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial
BACKGROUND: There is high medical need for safe long-term immunosuppression monotherapy in kidney transplantation. Selective targeting of post-transplant alloantigen-(re)activated effector-T cells by anti-TNF antibodies after global T cell depletion may allow safe drug minimization, however, it is u...
Autores principales: | Viklicky, Ondrej, Hruba, Petra, Tomiuk, Stefan, Schmitz, Sabrina, Gerstmayer, Bernhard, Sawitzki, Birgit, Miqueu, Patrick, Mrazova, Petra, Tycova, Irena, Svobodova, Eva, Honsova, Eva, Janssen, Uwe, Volk, Hans-Dieter, Reinke, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234822/ https://www.ncbi.nlm.nih.gov/pubmed/28085915 http://dx.doi.org/10.1371/journal.pone.0169624 |
Ejemplares similares
-
Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance
por: Krepsova, Eva, et al.
Publicado: (2015) -
Molecular Profiling of Acute and Chronic Rejections of Renal Allografts
por: Petra, Hřibová, et al.
Publicado: (2013) -
Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2018) -
Relevance and targeting of memory T cells in transplantation
por: Sawitzki, Birgit, et al.
Publicado: (2011) -
Early isolated V-lesion may not truly represent rejection of the kidney allograft
por: Wohlfahrtova, Mariana, et al.
Publicado: (2018)